Alkermes plc (NASDAQ: ALKS) today announced that data from studies of the company’s pipeline of drug candidates in schizophrenia and depression will be presented at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Hollywood, Florida, June 16-19, 2014.
Help employers find you! Check out all the jobs and post your resume.
